IM Cannabis Corp. (IMCC)
USD 1.73
(2.37%)
USD 1.73
(2.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.91 Million CAD | -34.21% |
| 2022 | 16.58 Million CAD | -46.63% |
| 2021 | 31.07 Million USD | 267.87% |
| 2020 | 8.44 Million CAD | 54.33% |
| 2019 | 5.47 Million CAD | -0.04% |
| 2018 | 5.47 Million CAD | 278.7% |
| 2017 | 1.44 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 3597.00 CAD | 8.31% |
| 2005 | 3321.00 CAD | 552.46% |
| 2004 | 509.00 CAD | -83.5% |
| 2003 | 3084.00 CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 6.5 Million CAD | -34.12% |
| 2024 Q1 | 8.68 Million CAD | -20.45% |
| 2023 Q1 | 16.15 Million USD | -2.59% |
| 2023 Q2 | 14.48 Million CAD | -10.35% |
| 2023 Q4 | 10.91 Million CAD | -1.08% |
| 2023 FY | 10.91 Million CAD | -34.21% |
| 2023 Q3 | 11.03 Million CAD | -23.84% |
| 2022 Q2 | 28.13 Million CAD | -13.38% |
| 2022 Q3 | 16.63 Million CAD | -40.88% |
| 2022 Q1 | 32.48 Million CAD | 4.53% |
| 2022 Q4 | 16.58 Million CAD | -0.29% |
| 2022 FY | 16.58 Million CAD | -46.63% |
| 2021 Q2 | 17.69 Million CAD | 19.27% |
| 2021 Q1 | 14.84 Million CAD | 75.66% |
| 2021 Q3 | 26.63 Million CAD | 50.47% |
| 2021 Q4 | 31.07 Million USD | 16.69% |
| 2021 FY | 31.07 Million USD | 267.87% |
| 2020 Q2 | 11.19 Million CAD | 8.36% |
| 2020 Q4 | 8.44 Million CAD | -24.69% |
| 2020 Q3 | 11.21 Million CAD | 0.22% |
| 2020 Q1 | 10.32 Million CAD | 29.32% |
| 2020 FY | 8.44 Million CAD | 54.33% |
| 2019 Q1 | 4.26 Million CAD | -22.21% |
| 2019 FY | 5.47 Million CAD | -0.04% |
| 2019 Q2 | 7.14 Million CAD | 67.79% |
| 2019 Q3 | 5.72 Million CAD | -19.98% |
| 2019 Q4 | 7.98 Million CAD | 39.63% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | 5.47 Million CAD | 278.7% |
| 2018 Q4 | 5.47 Million CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | 1.44 Million CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q1 | 3597.00 CAD | -64.99% |
| 2007 Q3 | 2838.00 CAD | 16.74% |
| 2007 Q2 | 2431.00 CAD | -32.42% |
| 2007 FY | - CAD | -100.0% |
| 2007 Q4 | - CAD | -100.0% |
| 2006 Q4 | 10.27 Thousand CAD | 61.15% |
| 2006 FY | 3597.00 CAD | 8.31% |
| 2006 Q2 | 2951.00 CAD | -11.14% |
| 2006 Q1 | 3321.00 CAD | -10.19% |
| 2006 Q3 | 6375.00 CAD | 116.03% |
| 2005 Q4 | 3698.00 CAD | 162.08% |
| 2005 FY | 3321.00 CAD | 552.46% |
| 2005 Q1 | 509.00 CAD | -87.63% |
| 2005 Q3 | 1411.00 CAD | -94.27% |
| 2005 Q2 | 24.61 Thousand CAD | 4736.54% |
| 2004 Q3 | 168.85 Thousand CAD | 10065.62% |
| 2004 Q4 | 4115.00 CAD | -97.56% |
| 2004 Q1 | 3084.00 CAD | -11.63% |
| 2004 FY | 509.00 CAD | -83.5% |
| 2004 Q2 | 1661.00 CAD | -46.14% |
| 2003 Q3 | 1055.00 CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 FY | 3084.00 CAD | 0.0% |
| 2003 Q4 | 3490.00 CAD | 230.81% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 65.62 Million USD | 83.372% |
| Theratechnologies Inc. | 6.06 Million USD | -79.888% |
| Safety Shot Inc | 1.86 Million USD | -483.64% |
| Cosmos Health Inc. | 4.78 Million USD | -127.853% |
| Cronos Group Inc. | 30.33 Million USD | 64.033% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1091199900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 61.378% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -226.387% |
| ProPhase Labs, Inc. | 3.84 Million USD | -184.093% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -301.324% |
| Dynavax Technologies Corporation | 53.29 Million USD | 79.523% |
| Radius Health, Inc. | 278.64 Million USD | 96.084% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1247.565% |
| Alvotech | 74.43 Million USD | 85.34% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -90.278% |
| Alpha Teknova, Inc. | 11.59 Million USD | 5.882% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 6.311% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Harrow Health, Inc. | 10.86 Million USD | -0.414% |
| Biofrontera Inc. | 10.9 Million USD | -0.037% |
| DURECT Corporation | 2.21 Million USD | -391.753% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 85.903% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.187% |
| OptiNose, Inc. | 8.05 Million USD | -35.519% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -91.471% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -61.205% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -136.736% |
| SIGA Technologies, Inc. | 64.21 Million USD | 83.008% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 72.706% |
| Shineco, Inc. | 1.58 Million USD | -586.927% |
| Phibro Animal Health Corporation | 265.91 Million USD | 95.896% |
| Procaps Group S.A. | 96.83 Million USD | 88.731% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7242.39% |
| Viatris Inc. | 3.46 Billion USD | 99.686% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -90.278% |
| Rockwell Medical, Inc. | 5.87 Million USD | -85.863% |
| Incannex Healthcare Limited | -10.01 Million USD | 208.957% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 13.623% |
| Tilray Brands, Inc. | 252.08 Million USD | 95.671% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 66.25% |
| PetIQ, Inc. | 159.3 Million USD | 93.15% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 71.509% |
| Journey Medical Corporation | 10.2 Million USD | -6.917% |
| Alimera Sciences, Inc. | 1.87 Million USD | -480.734% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -577.599% |
| Assertio Holdings, Inc. | 37.68 Million USD | 71.045% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 92.826% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4190.118% |
| Procaps Group, S.A. | 96.83 Million USD | 88.731% |
| PainReform Ltd. | - USD | -Infinity% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -5.125% |
| Hempacco Co., Inc. | 2.54 Million USD | -329.162% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 89.543% |
| Alvotech | 74.43 Million USD | 85.34% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 82.958% |
| Kamada Ltd. | 87.74 Million USD | 87.564% |
| Indivior PLC | 141.79 Million USD | 92.305% |
| Currenc Group, Inc. | 732.91 Thousand USD | -1388.857% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -2164.652% |
| Flora Growth Corp. | 8.5 Million USD | -28.256% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4190.118% |
| Evolus, Inc. | 10.99 Million USD | 0.782% |
| HUTCHMED (China) Limited | 50.25 Million USD | 78.288% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 89.689% |
| Akanda Corp. | 1.28 Million USD | -747.933% |